ZLAB Return on Tangible Equity | ZAI LAB LIMITED

ZAI LAB LIMITED (ZLAB) Return on Tangible Equity

2026-06-30: Return Tang Equity -36.11%.
2026-03-31: Return Tang Equity -30.38%.
2025-12-31: Return Tang Equity -27.46%.
2025-09-30: Return Tang Equity -29.35%.

Complete source-backed return tang equity history.

Available history: 2015-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-36.11%
2026-03-31	-30.38%
2025-12-31	-27.46%
2025-09-30	-29.35%
2025-06-30	-28.91%
2025-03-31	-33.41%
2024-12-31	-32.76%
2024-09-30	-43.97%
2024-06-30	-43.19%
2024-03-31	-45.27%
2023-12-31	-42.75%
2023-09-30	-34.16%
2023-06-30	-42.15%
2023-03-31	-40.95%
2022-12-31	-42.40%
2022-09-30	-53.65%
2022-06-30	-43.60%
2022-03-31	-42.35%
2021-12-31	-51.05%
2021-09-30	-35.84%
2021-06-30	-32.09%
2021-03-31	-44.95%
2020-12-31	-23.00%
2020-09-30	-20.96%
2020-06-30	-51.22%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-27.46%
2024-12-31	-32.76%
2023-12-31	-42.75%
2022-12-31	-42.40%
2021-12-31	-51.05%
2020-12-31	-23.00%
2019-12-31	-66.20%
2018-12-31	-55.39%
2017-12-31	-21.42%
2016-12-31	72.77%
2015-12-31	98.10%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Aurinia Pharmaceuticals Inc. (AUPH)		$2.207B	7.18
Prestige Consumer Healthcare Inc. (PBH)	United States	$2.163B	13.03
OCULAR THERAPEUTIX, INC (OCUL)	United States	$2.159B	-7.15
Viridian Therapeutics, Inc.\DE (VRDN)	United States	$2.342B	-5.38
Mineralys Therapeutics, Inc. (MLYS)	United States	$2.353B	-6.82
Bausch Health Companies Inc. (BHC)		$2.113B	-1.68
Braveheart Bio, Inc. (BRVE)	United States	$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)	United States	$2.105B	-35.55
Trevi Therapeutics, Inc. (TRVI)	United States	$2.091B	-51.93
Harmony Biosciences Holdings, Inc. (HRMY)	United States	$2.399B	11.67